238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.09%
Revenue growth 15-20% – Very strong. Benjamin Graham might confirm that the growth is organic rather than fueled solely by acquisitions.
12.01%
Gross profit growth 10-15% – Solid. Seth Klarman would see if consistent improvements are driven by genuine pricing power.
15.12%
EBIT growth 15-20% – Very strong. Benjamin Graham might check if the company is using leverage to boost EBIT artificially.
15.12%
Operating income growth 15-20% – Very strong. Benjamin Graham would verify leverage is not inflating operating results artificially.
5.37%
Net income growth 5-10% – Moderate. Philip Fisher would look at whether incremental improvements can accelerate with scale.
5.41%
EPS growth 5-10% – Moderate. Peter Lynch might look at potential for future expansions if the company maintains or increases margins.
5.56%
Diluted EPS growth 5-10% – Moderate. Peter Lynch would see if new product lines or expansions might lift future diluted EPS faster.
0.33%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
0.25%
Diluted share count up to +3% – Modest dilution. Howard Marks might tolerate it if used for high-ROI projects or strategic acquisitions.
No Data
No Data available this quarter, please select a different quarter.
-4.39%
Negative OCF growth is a critical warning sign. Benjamin Graham would check if receivables are ballooning or if core sales are declining.
-13.11%
Negative FCF growth reveals potential liquidity pressures or large capex overshadowing cash generation. Benjamin Graham would demand deeper scrutiny.
610.45%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
131.47%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
50.07%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
803.01%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
125.45%
5Y OCF/share CAGR above 15% – Very robust mid-term cash expansion. Warren Buffett would check if reinvestment fosters sustainable growth.
74.43%
3Y OCF/share CAGR above 15% – Rapid short-term expansion. Warren Buffett would see if this stems from genuine operational improvements vs. working-capital swings.
352.08%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
85.36%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
53.33%
3Y net income/share CAGR above 15% – Rapid short-term profit growth. Benjamin Graham would verify if it’s driven by core revenue or temporary cost reductions.
612.93%
10Y equity/share CAGR above 12% – Excellent long-term book value compounding. Warren Buffett would see if consistent profits plus moderate payouts drive this growth.
124.74%
5Y equity/share CAGR above 12% – Strong mid-term book value expansion. Warren Buffett would see if steady profits and moderate payout ratios sustain this pace.
54.57%
3Y equity/share CAGR above 12% – Excellent recent net worth expansion. Warren Buffett would check consistent earnings retention or beneficial buybacks driving this growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.82%
Receivables growth 10-15% – Some buildup. Peter Lynch checks if it aligns with similar revenue expansion.
-52.06%
Negative inventory growth can boost near-term margins if sales remain stable. Benjamin Graham still checks that it’s not from falling demand.
4.72%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
3.34%
2-5% annual BV/share growth – Mild. Peter Lynch sees potential if expansions or margin lifts can accelerate compounding.
-0.08%
A negative growth rate in debt means deleveraging, often positive for conservative investors. Benjamin Graham confirms it doesn’t restrict needed investments.
0.72%
R&D growth 0-10% – Balanced approach. Seth Klarman sees manageable cost if new products are still in development.
17.16%
SG&A growth above 15% – Aggressive expense expansion. Philip Fisher demands a compelling ROI argument for such heavy spending.